+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

France Diabetes Care Devices Market Outlook to 2025 - Glucose Monitoring and Insulin Delivery

  • PDF Icon

    Report

  • 121 Pages
  • April 2020
  • Region: France
  • GlobalData
  • ID: 5026875
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Summary

“France Diabetes Care Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the France Diabetes Care Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Glucose Monitoring and Insulin Delivery.

The France Diabetes Care Devices Market report provides key information and data on -
  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2019 company share and distribution share data for Diabetes Care Devices Market.
  • Global corporate-level profiles of key companies operating within the France Diabetes Care Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

France Diabetes Care Devices is segmented as follows -
  • Glucose Monitoring and Insulin Delivery

Reasons to Buy

The France Diabetes Care Devices Market report helps you to develop -
  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Diabetes Care Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Diabetes Care Devices Market, France
3.1 Diabetes Care Devices Market, France, Revenue ($m), 2015-2025
3.2 Diabetes Care Devices Market, France, Revenue Mix ($m), 2019
3.3 Diabetes Care Devices Market, France, Category Contribution by Revenue ($m), 2019
3.4 Diabetes Care Devices Market, France, Revenue ($m), 2015-2025
3.5 Diabetes Care Devices Market, France, Volume (Units), 2015-2025
3.6 Diabetes Care Devices Market, France, Volume (Units), 2015-2025
3.7 Diabetes Care Devices Market, France, Company Share by Revenue ($m), 2019
4 Glucose Monitoring Market, France
4.1 Glucose Monitoring Market, France, Revenue ($m), 2015-2025
4.1.1 Blood Glucose Meters Market, France, Revenue ($m), by Segment, 2015-2025
4.2 Glucose Monitoring Market, France, Volume (Units), 2015-2025
4.2.1 Blood Glucose Meters Market, France, Volume (Units), by Segment, 2015-2025
4.3 Glucose Monitoring Market, France, Average Price ($) , 2015-2025
4.4 Glucose Monitoring Market, France, Distribution Share by Revenue ($m), 2019
4.5 Glucose Monitoring Market, France, Company Share by Revenue ($m), 2019
5 Insulin Delivery Market, France
5.1 Insulin Delivery Market, France, Revenue Mix ($m), 2019
5.2 Insulin Delivery Market, France, Segment Contribution (%), 2019
5.3 Insulin Delivery Market, France, Revenue ($m), 2015-2025
5.3.1 Insulin Pens Market, France, Revenue ($m), by Segment, 2015-2025
5.3.2 Insulin Pumps Market, France, Revenue ($m), by Segment, 2015-2025
5.4 Insulin Delivery Market, France, Volume (Units), 2015-2025
5.4.1 Insulin Pens Market, France, Volume (Units), by Segment, 2015-2025
5.4.2 Insulin Pumps Market, France, Volume (Units), by Segment, 2015-2025
5.5 Insulin Delivery Market, France, Average Price ($), 2015-2025
5.6 Insulin Delivery Market, France, Distribution Share by Revenue ($m), 2019
5.7 Insulin Delivery Market, France, Company Share by Revenue ($m), 2019
6 Overview of Key Companies in France, Diabetes Care Devices Market
6.1 DexCom Inc
6.1.1 Company Overview
6.2 Medtronic Plc
6.2.1 Company Overview
6.3 Abbott Laboratories
6.3.1 Company Overview
6.4 Novo Nordisk AS
6.4.1 Company Overview
6.5 Sanofi
6.5.1 Company Overview
6.6 Eli Lilly and Co
6.6.1 Company Overview
6.7 F. Hoffmann-La Roche Ltd
6.7.1 Company Overview
6.8 Ypsomed Holding AG
6.8.1 Company Overview
7 Diabetes Care Devices Market Pipeline Products
8 Financial Deals Landscape
8.1 Debt Offerings
8.1.1 Sanofi Prices Public Offering of 1.000% Notes Due 2025 for USD804.8 Million
8.1.2 Sanofi Prices Public Offering of 1.500% Notes Due 2030 for USD804.8 Million
8.2 Equity Offerings
8.2.1 Beurer Invests USD2.51 Million in PKvitality
8.3 Partnerships
8.3.1 Biocorp Production Enters into Agreement with Amalgam Rx (iSage Rx)
8.3.2 Sanofi and Abbott Enter into Partnership
8.3.3 LifeScan Enters into Distribution Agreement with Sanvita Medical
8.3.4 Diabeloop and ViCentra Enter into Distribution Agreement
8.4 Venture Financing
8.4.1 Diabeloop Raises USD34 Million in Series B Financing
9 Recent Developments
9.1 Corporate Communications
9.1.1 Mar 04, 2020: Sanofi's Board of Directors proposes the appointment of Rachel Duan and Lise Kingo as independent directors
9.1.2 Feb 25, 2020: Sanofi announces resignation of Director
9.1.3 Dec 04, 2019: Duke Health: New, non-hormonal target identified for advanced prostate cancer
9.1.4 Oct 15, 2019: Northwell Health extends partnership with comprehensive Allscripts Sunrise platform through 2027
9.1.5 Jul 29, 2019: Sanofi: Appointment of additional director and whole time director
9.1.6 Jul 26, 2019: Sanofi : Information on the departure conditions of Olivier Brandicourt, Chief Executive Officer
9.1.7 Jun 07, 2019: Paul Hudson to succeed Olivier Brandicourt as chief executive officer
9.1.8 Apr 09, 2019: Voluntis appoints Berkley Nelson as Chief Growth Officer
9.2 Financial Announcements
9.2.1 Feb 06, 2020: Sanofi delivers strong 2019 business EPS growth of 6.8% at CER
9.2.2 Jan 27, 2020: Theraclion demonstrates its leadership in thyroid and veins none invasive treatments
9.2.3 Oct 31, 2019: Sanofi Q3 well on track
9.2.4 Oct 17, 2019: The Bristol-Myers Squibb-Pfizer alliance and Fitbit collaborate to address gaps in Atrial Fibrillation Detection with the aim of accelerating diagnosis
9.2.5 Sep 19, 2019: Voluntis reports business review and financial results for first half of 2019
9.2.6 Sep 16, 2019: Theraclion: Half year results 2019
9.2.7 Jul 29, 2019: Sanofi delivered solid growth in Q2 2019
9.2.8 Jul 22, 2019: Growth in first half 2019 sales of Theraclion SA: + 12%
9.2.9 May 15, 2019: Atara Biotherapeutics announces presentations highlighting Mesothelin-Targeted CAR T clinical results at American Society of Clinical Oncology (ASCO) Annual Meeting
9.3 Legal And Regulatory
9.3.1 Oct 03, 2019: Lilly announces voluntary delisting from Euronext Paris
9.3.2 Sep 30, 2019: Adocia announces receipt of USD 14.3 million payment from Eli Lilly following arbitration conclusion and the decision by mutual consent with Eli Lilly to conclude the civil case
9.3.3 Aug 23, 2019: Adocia announces that the American Arbitration Association Tribunal Dismissed all Claims in Second Phase of Arbitration With Eli Lilly
9.4 Other Significant Developments
9.4.1 Jan 14, 2020: BIOCORP and SANOFI strengthen their partnership with Mallya Smart Sensors
9.4.2 Jun 19, 2019: Gamida Cell and Lonza establish commercial manufacturing agreement for omidubicel
9.4.3 Apr 26, 2019: Sanofi delivers strong Q1 2019 business EPS growth of 9.4% at CER
9.4.4 Apr 10, 2019: Sanofi provides unprecedented access to its insulins for one set monthly price
9.5 Research And Development
9.5.1 Sep 13, 2019: Aimmune stock trading halted; FDA Allergenic Products Advisory Committee (APAC) meeting to discuss PALFORZIA (AR101) for Peanut Allergy
9.6 Strategy And Business Planning
9.6.1 Oct 15, 2019: Sanofi opens digital manufacturing facility in the US
9.6.2 May 21, 2019: Verily forms strategic alliances with Novartis, Otsuka, Pfizer and Sanofi to transform clinical research
10 Appendix
10.1 Research Methodology
10.1.1 Coverage
10.1.2 Secondary Research
10.1.3 Primary Research
10.1.4 Market Modeling and Forecasting
10.1.5 Company Share Analysis
10.1.6 Distribution Share Analysis
10.1.7 Benchmarking
10.2 Consulting
10.3 Contact
10.4 Disclaimer
List of Tables
Table 1: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, 2015-2025
Table 2: Diabetes Care Devices Market, France, Category Contribution by Revenue ($m), 2019
Table 3: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, Historic, 2015-2020
Table 4: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, Forecast, 2021-2025
Table 5: Diabetes Care Devices Market, France, Volume (Units), 2015-2025
Table 6: Diabetes Care Devices Market, France, Volume (Units), Historic, 2015-2020
Table 7: Diabetes Care Devices Market, France, Volume (Units), Forecast, 2021-2025
Table 8: Diabetes Care Devices Market, France, Company Share by Revenue ($m), USD Constant, 2019
Table 9: Glucose Monitoring Market, France, Revenue ($m), USD Constant, 2015-2020
Table 10: Glucose Monitoring Market, France, Revenue ($m), USD Constant, 2021-2025
Table 11: Blood Glucose Meters Market, France, Revenue ($m), USD Constant, 2015-2020
Table 12: Blood Glucose Meters Market, France, Revenue ($m), USD Constant, 2021-2025
Table 13: Glucose Monitoring Market, France, Volume (Units), 2015-2020
Table 14: Glucose Monitoring Market, France, Volume (Units), 2021-2025
Table 15: Blood Glucose Meters Market, France, Volume (Units), 2015-2020
Table 16: Blood Glucose Meters Market, France, Volume (Units), 2021-2025
Table 17: Glucose Monitoring Market, France, Average Price ($), 2015-2020
Table 18: Glucose Monitoring Market, France, Average Price ($), 2021-2025
Table 19: Glucose Monitoring Market, France, Distribution Share by Revenue ($m), USD Constant, 2019
Table 20: Glucose Monitoring Market, France, Company Share by Revenue ($m), USD Constant, 2019
Table 21: Insulin Delivery Market, France, Segment Contribution (%), 2019
Table 22: Insulin Delivery Market, France, Revenue ($m), USD Constant, 2015-2020
Table 23: Insulin Delivery Market, France, Revenue ($m), USD Constant, 2021-2025
Table 24: Insulin Pens Market, France, Revenue ($m), USD Constant, 2015-2020
Table 25: Insulin Pens Market, France, Revenue ($m), USD Constant, 2021-2025
Table 26: Insulin Pumps Market, France, Revenue ($m), USD Constant, 2015-2020
Table 27: Insulin Pumps Market, France, Revenue ($m), USD Constant, 2021-2025
Table 28: Insulin Delivery Market, France, Volume (Units), 2015-2020
Table 29: Insulin Delivery Market, France, Volume (Units), 2021-2025
Table 30: Insulin Pens Market, France, Volume (Units), 2015-2020
Table 31: Insulin Pens Market, France, Volume (Units), 2021-2025
Table 32: Insulin Pumps Market, France, Volume (Units), 2015-2020
Table 33: Insulin Pumps Market, France, Volume (Units), 2021-2025
Table 34: Insulin Delivery Market, France, Average Price ($), 2015-2020
Table 35: Insulin Delivery Market, France, Average Price ($), 2021-2025
Table 36: Insulin Delivery Market, France, Distribution Share by Revenue ($m), USD Constant, 2019
Table 37: Insulin Delivery Market, France, Company Share by Revenue ($m), USD Constant, 2019
Table 38: Diabetes Care Devices Market Pipeline Products
Table 39: Sanofi Prices Public Offering of 1.000% Notes Due 2025 for USD804.8 Million
Table 40: Sanofi Prices Public Offering of 1.500% Notes Due 2030 for USD804.8 Million
Table 41: Beurer Invests USD2.51 Million in PKvitality
Table 42: Biocorp Production Enters into Agreement with Amalgam Rx (iSage Rx)
Table 43: Sanofi and Abbott Enter into Partnership
Table 44: LifeScan Enters into Distribution Agreement with Sanvita Medical
Table 45: Diabeloop and ViCentra Enter into Distribution Agreement
Table 46: Diabeloop Raises USD34 Million in Series B Financing
List of Figures
Figure 1: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, 2015-2025
Figure 2: Diabetes Care Devices Market, France, Revenue Mix ($m), 2019
Figure 3: Diabetes Care Devices Market, France, Category Contribution (%), 2019
Figure 4: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, Historic, 2015-2025
Figure 5: Diabetes Care Devices Market, France, Volume (Units), 2015-2025
Figure 6: Diabetes Care Devices Market, France, Volume (Units), Historic, 2015-2025
Figure 7: Diabetes Care Devices Market, France, Company Share (%) 2019
Figure 8: Glucose Monitoring Market, France, Revenue ($m), USD Constant, 2015-2025
Figure 9: Blood Glucose Meters Market, France, Revenue ($m), USD Constant, 2015-2025
Figure 10: Glucose Monitoring Market, France, Volume (Units), 2015-2025
Figure 11: Blood Glucose Meters Market, France, Volume (Units), 2015-2025
Figure 12: Glucose Monitoring Market, France, Company Share (%) 2019
Figure 13: Insulin Delivery Market, France, Revenue Mix ($m), 2019
Figure 14: Insulin Delivery Market, France, Segment Contribution (%), 2019
Figure 15: Insulin Delivery Market, France, Revenue ($m), USD Constant, 2015-2025
Figure 16: Insulin Pens Market, France, Revenue ($m), USD Constant, 2015-2025
Figure 17: Insulin Pumps Market, France, Revenue ($m), USD Constant, 2015-2025
Figure 18: Insulin Delivery Market, France, Volume (Units), 2015-2025
Figure 19: Insulin Pens Market, France, Volume (Units), 2015-2025
Figure 20: Insulin Pumps Market, France, Volume (Units), 2015-2025
Figure 21: Insulin Delivery Market, France, Company Share (%) 2019 49

Companies Mentioned

A selection of companies mentioned in this report includes:

  • DexCom Inc
  • Medtronic Plc
  • Abbott Laboratories